Skip to main
ADUS
ADUS logo

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 11%
Sell 11%
Strong Sell 0%

Bulls say

Addus HomeCare has demonstrated robust organic revenue growth in its personal care segment, reporting an impressive 12.3% year-over-year increase in 2023, with continued growth projected at 7.7% for 2024 and 7.4% year-to-date in 2025. The recently finalized Medicare hospice rate increase of 2.6% is anticipated to bolster revenue for the Hospice segment, which is expected to achieve steady growth rates of 5% to 7% facilitated by operational improvements and potential mergers and acquisitions. Given these positive financial trends and the ongoing demand for in-home care services, Addus HomeCare presents a favorable outlook for future growth.

Bears say

Addus HomeCare's financial outlook is negatively impacted by ongoing declines in same-store revenues, primarily due to Medicaid redeterminations causing administrative delays that hinder patient onboarding and result in higher discharge rates than admissions. Additionally, approximately 97% of the company's segment revenues are tied to Medicaid, creating significant uncertainty regarding future funding as a result of the One Big Beautiful Bill Act (OBBBA). Despite strong execution and a business model poised for long-term demand, the disconnect between equity valuation and fundamental performance raises concerns about the company's relative viability in the post-acute care market.

Addus HomeCare (ADUS) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 9 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.